The Body's Opioid System Prevents Premature Labor by Suppressing Oxytocin

Naloxone (opioid blocker) increased oxytocin levels during late pregnancy but not in non-pregnant or post-partum rats, revealing an opioid brake on oxytocin that prevents premature labor.

Douglas, A J et al.·Journal of neuroendocrinology·1993·Moderate EvidenceAnimal StudyAnimal Study
RPEP-00261Animal StudyModerate Evidence1993RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Naloxone significantly increased plasma oxytocin on days 15, 18, and 21 of pregnancy but not in non-pregnant, early pregnant, or post-partum rats.

Key Numbers

How They Did This

Conscious rats were blood-sampled at multiple pregnancy stages. Naloxone or vehicle was injected, and plasma oxytocin was measured by radioimmunoassay.

Why This Research Matters

This reveals a natural mechanism that prevents premature labor. The body's opioid peptides suppress oxytocin during pregnancy. When this brake is released, labor can proceed.

The Bigger Picture

Premature labor is a leading cause of infant illness and death. Understanding that the opioid system naturally suppresses oxytocin during pregnancy could lead to new strategies for preventing preterm birth.

What This Study Doesn't Tell Us

Animal study in rats. Rat pregnancy is shorter than human. The specific opioid peptides involved were not identified. Clinical translation needs confirmation.

Questions This Raises

  • ?Could enhancing opioid signaling help prevent premature labor in at-risk women?
  • ?What triggers the release of this opioid brake to allow labor to begin?

Trust & Context

Key Stat:
Pregnancy-specific opioid brake Naloxone only increased oxytocin during late pregnancy (days 15-21), not before or after — a precisely timed suppressive mechanism
Evidence Grade:
Moderate — animal study with clear pregnancy-stage-specific results in conscious rats. Well-designed with appropriate controls across pregnancy stages.
Study Age:
Published in 1993 (33 years ago). Opioid regulation of oxytocin during pregnancy is now an established concept in reproductive physiology.
Original Title:
Endogenous opioid regulation of oxytocin secretion through pregnancy in the rat.
Published In:
Journal of neuroendocrinology, 5(3), 307-14 (1993)
Database ID:
RPEP-00261

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

How do opioids prevent premature labor?

During late pregnancy, the body's natural opioid peptides suppress oxytocin release. Since oxytocin triggers uterine contractions, this opioid brake prevents premature labor until the body is ready for delivery.

What happens when the brake is released?

As the body prepares for labor, the opioid suppression of oxytocin is removed, allowing oxytocin to rise and trigger contractions. Understanding what controls this timing could help prevent both premature and overdue deliveries.

Read More on RethinkPeptides

Cite This Study

RPEP-00261·https://rethinkpeptides.com/research/RPEP-00261

APA

Douglas, A J; Dye, S; Leng, G; Russell, J A; Bicknell, R J. (1993). Endogenous opioid regulation of oxytocin secretion through pregnancy in the rat.. Journal of neuroendocrinology, 5(3), 307-14.

MLA

Douglas, A J, et al. "Endogenous opioid regulation of oxytocin secretion through pregnancy in the rat.." Journal of neuroendocrinology, 1993.

RethinkPeptides

RethinkPeptides Research Database. "Endogenous opioid regulation of oxytocin secretion through p..." RPEP-00261. Retrieved from https://rethinkpeptides.com/research/douglas-1993-endogenous-opioid-regulation-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.